Support for Children with Cancer in Physical Activity Programs
Evaluation of the Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity
This study is testing a personalized exercise program for kids and teens with cancer to see if it helps them stick to being active by understanding their challenges and motivations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 48 (estimated) |
| Ages | 3 Years to 17 Years |
| Sex | All |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Grenoble, Isere) |
| Trial ID | NCT06230016 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the adherence of children and adolescents with newly diagnosed cancer or relapse to a personalized adapted physical activity (APA) program. It involves assessing motivations and barriers through questionnaires before the program starts and again after 4 to 6 months of participation. The goal is to enhance long-term adherence to physical activity by identifying and addressing obstacles faced by young patients and their parents. The study is conducted at the Grenoble Alpes University Hospital as part of routine care in the immuno-hematological service.
Who should consider this trial
Good fit: Ideal candidates are children aged 3 to under 18 years with a new cancer diagnosis or relapse who have not previously participated in an adapted physical activity program.
Not a fit: Patients with strict medical contraindications to physical activity, such as unstable heart or lung disease, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the long-term physical activity engagement of children with cancer, enhancing their overall health and quality of life.
How similar studies have performed: While there is a wealth of literature on physical activity in oncology, this specific approach focusing on pediatric patients and personalized interventions is relatively novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 3 years to under 18 years under care at Grenoble Alpes University Hospital * New cancer diagnosis or relapse in the absence of previous APA treatment * All cancer pathologies: Diagnosis of acute or chronic hematological malignancy OR Central nervous system tumors OR Other solid tumors * Regardless of therapeutic pathway * Parents and patient over 5 years old understanding french langage * Patient and parents who have not objected to participation after being informed Exclusion Criteria: * Patient with a strict medical contraindication to physical activity identified by the referring physician or another specialist physician, particularly the sports physician (unstabilized heart or lung disease, uncontrolled diabetes, etc.)
Where this trial is running
Grenoble, Isere
- CHU Grenoble Alpes — Grenoble, Isere, France (Recruiting)
Study contacts
- Principal investigator: Leila Gofti Laroche, MD — CHU Grenoble Alpes
- Study coordinator: Isabelle Schiff, PHD
- Email: ISchiff@chu-grenoble.fr
- Phone: +33476766561
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.